Alpha Cubed Investments’s CorMedix CRMD Stock Holding History

Alpha Cubed Investments’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$25K	–	192
2016 Q3	$25K	Hold	2,000	–	–	0.01%	177
2016 Q2	$20K	Hold	2,000	–	–	0.01%	145
2016 Q1	$27K	Hold	2,000	–	–	0.01%	157
2015 Q4	$20K	Hold	2,000	–	–	0.01%	176
2015 Q3	$25K	Hold	2,000	–	–	0.01%	189
2015 Q2	$39K	Buy	+2,000	New	+$68.6K	0.01%	182

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alpha Cubed Investments's CRMD Position: Q4 2016 in Review

Alpha Cubed Investments sold out of CorMedix (CRMD) in Q4 2016, closing a stake of 2,000 shares — an estimated $25K sold.

Alpha Cubed Investments first reported a position in CRMD in Q2 2015 and held it in 6 quarters. The position peaked at $39K in Q2 2015. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

Alpha Cubed Investments reported no remaining CorMedix position as of Q4 2016 after selling out during the quarter.
Alpha Cubed Investments sold 2,000 CorMedix shares in Q4 2016, an estimated $25K.
Alpha Cubed Investments first reported a position in CorMedix in Q2 2015 and held it in 6 quarters.
Alpha Cubed Investments's CorMedix position peaked at $39K in Q2 2015.
38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on Alpha Cubed Investments's 13F filing for Q4 2016, filed 30 Jan 2017.